The prostate is a very important organ for men, so if problems are found, they should be checked and treated in time. The incidence of prostate cancer has been increasing in recent years, which makes people very scared. Let’s take a look at prostate cancer for radiotherapy. Is it sensitive?

　　Is prostate cancer sensitive to radiation therapy? It is necessary to look at the specific condition of the prostate cancer patient to see the condition, and how the patient''s physique is, whether it can tolerate chemotherapy is related. And it is important to look at the sensitivity of cancer cells to radiotherapy. Everyone''s situation is different, and the sensitivity is different.

　　In order to make the radiotherapy effect of patients with prostate cancer better, it is recommended that patients can eat Cordyceps capsules or vitamins during chemotherapy to reduce side effects, and in addition to chemotherapy, it is recommended that patients can use surgery Combined with radiotherapy, or combined with chemotherapy and other methods for treatment. It is necessary to pay attention to the diet during radiation therapy of prostate cancer. It is recommended that patients with prostate cancer do not smoke and drink, and it is best for patients to drink coffee. It is also recommended that patients with prostate cancer should not eat spicy spicy foods, and it is best not to eat onions and garlic.

　　 Patients with chemotherapy damage should not continue with chemotherapy. We all know that chemotherapy has very serious side effects. Some patients have received radical radiation therapy for their tissues and organs. If chemotherapy is given again at this time, radiation damage is likely to occur, and radiation therapy is generally not available. Chemotherapy is not suitable for treating all tumors, because some tumors are not sensitive to radiation therapy. If chemotherapy is used, the effect is not obvious, and it will also cause radiation damage. Radiation therapy is generally not recommended for tumors such as fibrosarcoma, liposarcoma, synovial sarcoma, leiomyosarcoma, and neurofibrosarcoma.